Nov 11, 2020 / 04:45PM GMT
Matt Miksic - Credit Suisse - Analyst
Great. So I think we're live. Thanks, everyone, for joining us. We are very, very pleased to have with us today a team from Johnson & Johnson, Joaquin Duato, Vice Chairman, Chairman of Executive Committee; and Thibaut Mongon, who's EVP of Worldwide, Chairman of Consumer. So plenty to talk about in pharma and research, plenty to talk about in consumer.
Questions and Answers:
Matt Miksic - Credit Suisse - AnalystWe're going to sort of jump right into some broad topics, since most of the folks, I think, joining us have some familiarity with J&J. But maybe to get it out of the way early, there's been a lot of news this week on vaccines. So maybe, Joaquin, if you could take a minute to sort of give us your overview, updated thoughts or next steps, and sort of a rough time line of where your program stands. Thoughts, if you have any, on the results and progress that others are making, I'm sure everyone would be interested in that type of update.
Joaquin Duato - Johnson & Johnson -